Endpoints of hepatitis B treatment.

@article{Chotiyaputta2010EndpointsOH,
  title={Endpoints of hepatitis B treatment.},
  author={Watcharasak Chotiyaputta and Anna Suk-Fong Lok},
  journal={Journal of viral hepatitis},
  year={2010},
  volume={17 10},
  pages={
          675-84
        }
}
  • Watcharasak Chotiyaputta, Anna Suk-Fong Lok
  • Published 2010
  • Medicine
  • Journal of viral hepatitis
  • The goal of hepatitis B treatment is to prevent the development of cirrhosis, liver failure, and hepatocellular carcinoma. Ideally, clinical studies should demonstrate that hepatitis B therapies can prevent liver-related complications; however, these clinical endpoints evolve over years or decades. Therefore, clinical trials have relied on intermediate endpoints to evaluate the efficacy of treatment and to determine when treatment can be stopped. Intermediate endpoints that have been used… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 15 CITATIONS

    Drug Delivery Strategies for Antivirals against Hepatitis B Virus

    VIEW 2 EXCERPTS
    CITES BACKGROUND

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 87 REFERENCES

    Surrogate end points and long-term outcome in patients with chronic hepatitis B.